Abbott’s ID NOW™ testing platform has emerged as an alternative to PCR for more rapid molecular detection of SARS-CoV-2 at the point of care with NEAR detection technology.
Read More
Nordic Bioscience is collaborating with Roche for the development of proprietary biomarkers involved in tissue breakdown and build-up.
Read More
Acutis Diagnostics, a New York State laboratory, is developing advanced gene sequencing technologies that can be used in the clinic.
Read More
A study found that the rate of hepatitis C antibody screening is low, with nearly 41% of pregnant people receiving screening in early 2021.
Read More
Analyzing SARS-CoV-2 samples from university screening programs, allowed researchers to gather critical data about the Omicron variant.
Read More